These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19119512)

  • 41. Bonding with patients.
    Chaudhuri SK
    J Indian Med Assoc; 2009 May; 107(5):324. PubMed ID: 19886388
    [No Abstract]   [Full Text] [Related]  

  • 42. Rifampicin-induced thrombocytopenia.
    Krishnappriya R
    J Assoc Physicians India; 2009 Mar; 57():213. PubMed ID: 19588650
    [No Abstract]   [Full Text] [Related]  

  • 43. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.
    Aguado JM; Torre-Cisneros J; Fortún J; Benito N; Meije Y; Doblas A; Muñoz P
    Clin Infect Dis; 2009 May; 48(9):1276-84. PubMed ID: 19320593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2009 Oct; 7(86):75-82; quiz 2 p after 82. PubMed ID: 19794340
    [No Abstract]   [Full Text] [Related]  

  • 45. Meropenem-clavulanate: a new strategy for the treatment of tuberculosis?
    Holzgrabe U
    ChemMedChem; 2009 Jul; 4(7):1051-3. PubMed ID: 19462395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicentre study of nitrate reductase assay for rapid detection of rifampicin-resistant M. tuberculosis.
    Shikama ML; Ferro e Silva R; Villela G; Sato DN; Martins MC; Giampaglia CM; da Silva RF; Ferro e Silva P; da Silva Telles MA; Martin A; Palomino JC
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):377-80. PubMed ID: 19275800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paediatric tuberculosis and DOTS strategy under RNTCP.
    Chugh S
    J Indian Med Assoc; 2008 Dec; 106(12):799-802. PubMed ID: 19370953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is this the time to revise the Revised National Tuberculosis Control Programme in India?--yes and no..
    Jindal SK; Agarwal R
    Natl Med J India; 2008; 21(4):159-62. PubMed ID: 19267034
    [No Abstract]   [Full Text] [Related]  

  • 49. Supplying quality-assured child-friendly anti-tuberculosis drugs to children.
    Gie RP; Matiru RH
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):277-8. PubMed ID: 19275783
    [No Abstract]   [Full Text] [Related]  

  • 50. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori.
    Suzuki S; Suzuki H; Nishizawa T; Kaneko F; Ootani S; Muraoka H; Saito Y; Kobayashi I; Hibi T
    Digestion; 2009; 79(1):1-4. PubMed ID: 19142036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lost in transcription--inhibition of RNA polymerase.
    Haebich D; von Nussbaum F
    Angew Chem Int Ed Engl; 2009; 48(19):3397-400. PubMed ID: 19294713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.
    Tabarsi P; Chitsaz E; Moradi A; Baghaei P; Farnia P; Marjani M; Irannejad P; Mansouri D; Masjedi M
    Int J STD AIDS; 2009 Aug; 20(8):566-70. PubMed ID: 19625590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Characterization of the drug resistance spectrum of rifampicin-resistant M. tuberculosis to other first-line antituberculous drugs].
    Isakova ZhT; Goncharova ZK; Aldashev AA
    Probl Tuberk Bolezn Legk; 2008; (11):39-42. PubMed ID: 19140379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cervicofacial nontuberculous mycobacterium lymphadenitis in children: is surgery always necessary?
    Harris RL; Modayil P; Adam J; Sharland M; Heath P; Planche T; Daya H
    Int J Pediatr Otorhinolaryngol; 2009 Sep; 73(9):1297-301. PubMed ID: 19586666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Esophageal tuberculosis in a patient on maintenance dialysis: advantages of interferon-gamma release assay.
    Damaschin O; Dahmani O; Faibis F; Demachy MC; Abtahi M; Cucherousset N; Fiacre A; Locher C; Habibi H; Kamalodine T; Morteza Massoumi S
    Ren Fail; 2009; 31(3):248-50. PubMed ID: 19288332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Definite case of tuberculosis].
    Sadoun V
    Rev Infirm; 2008 Dec; (146):41-2. PubMed ID: 19157194
    [No Abstract]   [Full Text] [Related]  

  • 57. Ritual and the organisation of care in primary care clinics in Cape Town, South Africa.
    Lewin S; Green J
    Soc Sci Med; 2009 Apr; 68(8):1464-71. PubMed ID: 19278764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 59. Case report: Esophageal histoplasmosis associated with disseminated tuberculosis in acquired immunodeficiency syndrome.
    Rezende RE; Brunaldi MO; Girão MS; Zucoloto S; Garcia SB; Machado AA; Módena JL
    Am J Trop Med Hyg; 2009 Mar; 80(3):347-50. PubMed ID: 19270280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
    Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
    Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.